Microarray
DNA methylation analysis could expand cancer gene therapy possibilities
Published in Gene Therapy Weekly, February 27th, 2003
"Gene silencing via promoter CpG island hypermethylation offers tumor cells growth advantages. This epigenetic event is pharmacologically reversible, and uncovering a unique set of methylation-silenced genes in tumor cells can bring a new avenue to cancer treatment. However, high-throughput tools capable of surveying the methylation status of multiple gene promoters are needed for this discovery process," wrote H.D. Shi and colleagues, University of Missouri, Ellis Fischel Cancer Center.
"Herein we describe...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2003-02-27)
More Articles from Gene Therapy Weekly
- Hepatocellular Carcinoma
Antisense strategy may reduce growth and invasion of liver cancer - Lung Transplantation
Airway gene transfer mitigates post-transplantation complication - Dermatology
Complexes heighten iontophoresis-mediated gene transfer to the skin - Gene Delivery
Polymeric nanogels are potential gene and antisense delivery agents - Thalassemia
Gene restoration yields hemoglobin A from progenitor cells - Virus Vectors
Chimeras redirect adenovirus transduction in vitro and in vivo - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
